Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-23T06:49:19.472Z Has data issue: false hasContentIssue false
  • English
  • Français

Human T-Cell Lymphotropic Virus-Type I

Published online by Cambridge University Press:  21 June 2016

Julie Larkin ,
John T. Sinnott IV ,
Joshua Weiss  and
Douglas A. Holt
Julie Larkin
Affiliation:
Division of Infectious and Tropical Diseases, Department of Internal Medicine, University of South Florida College of Medicine, ‘Tampa, Florida
John T. Sinnott IV*
Affiliation:
Department of Epidemiology, The Tampa General Hospital, ‘Tampa, Florida
Joshua Weiss
Affiliation:
Division of Infectious and Tropical Diseases, Department of Internal Medicine, University of South Florida College of Medicine, ‘Tampa, Florida
Douglas A. Holt
Affiliation:
Division of Infectious and Tropical Diseases, Department of Internal Medicine, University of South Florida College of Medicine, ‘Tampa, Florida
*
Director of Epidemiology, The Tampa General Hospital, PO Box 1289, Tampa, FL 33601
Get access Rights & Permissions [Opens in a new window]

Extract

Human T-cell lymphotropic virus type-1 (HTLV-I) is a recently recognized retrovirus identified as the cause of adult T-cell leukemia-lymphoma (ATLL) and HTLV-I-associated myelopathy (TSPI HAM). HTLV-I, a member of the Retroviridae family of viruses, was first described in 1980 after the isolation of the virus from a patient with a T-cell lymphoma. These pathogenic retroviruses are typically divided into the Oncovirinae and Lentivirinae. The oncovirus group, including HTLV-I, HTLV-II and bovine leukemia virus (BLV), is generally associated with tumors. The lentiviruses are associated with immune deficiency and/or neurologic disease, and include agents such as the visna virus of sheep and the human immunodeficiency virus type-1 and -2 HIV-1 and HIV-2).

Type
Special Sections
Information
Infection Control & Hospital Epidemiology , Volume 11 , Issue 6 , June 1990 , pp. 314 - 318
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Poiesz, BJ, Ruscetti, FW, Gazdar, AF, Bunn, PA, Minna, JD, Gallo, RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U.S.A. 1981;77:7415–7419.CrossRefGoogle Scholar
2. Jawetz, E, Melnick, JL, Adelberg, EA. Review of Medical Microbiology. 17th ed. Norwalk, Conn/Los Altos, Ca: Appleton and Lange: 1987.Google Scholar
3. Anderson, D. Epstein, J, Pierik, L, et al. Licensure and screening tests for antibody to human T-lymphotopic virus type-l. MMWR. 1988;37:736–747.Google Scholar
4. Kwok, S, Kellogg, D, Ehrlich, G, Poiesz, B, Bhagauati, S, Snisky, JJ. Characterization of a sequence of human T-cell leukemia virus from a patient with chronic progressive myelopathy. J Infect Dis. 1988;158:1193–1197.CrossRefGoogle ScholarPubMed
5. Bangham, CR, Daenke, S, Phillips, R, Cruickshank, JK, Bell, JI. Enzymatic amplification of exogenous and endogenous retroviral sequences from DNA of patients with tropical spastic paraparesis. EMBO J. 1988;7:4179–4184.CrossRefGoogle ScholarPubMed
6. Nakamura, T Tsujihata, M, Shirabe, S, Matsuo, H. Ueki Yt Nagataki S. Characterization of HTLV-I in a T-cell line established from a patient with myelopathy. Arch Neurol. 1989;46:35–37.CrossRefGoogle Scholar
7. Hinuma, Y, Komoda, H. Chosa, T. et al. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer. 1982;29:631–635.CrossRefGoogle ScholarPubMed
8. Blattner, WA, Kalyanaraman, VS. Robert-Guroff, M, et al. The human type-C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer. 1983;30:257–264.CrossRefGoogle Scholar
9. Gibbs, WN, Loiters, WS, Campbell, M, et al. Non-Hodgkm's lymphoma in Jamaica and its relation to adult T-cell leukemia-lymphoma. Ann Intern Med. 1987;106:361–368.CrossRefGoogle ScholarPubMed
10. Fleming, AF, Majarajan, R, Abraham, M. et al. Antibodies to HTLV-I in Nigeria blood-donors, their relatives and patients with leukemias lymphomas and other diseases. Int J Cancer. 1986;38:809–813.CrossRefGoogle ScholarPubMed
11. Cartes, E, Detels, R, Aboulafia, D, et al. HIV-1. HIV-2. and HTLV-1 infection in high-risk groups in Brazil. N Engl J Med. 1989;320:953–958.CrossRefGoogle Scholar
12. Cartier-Rovirosa, L. Mora, C, Araya, F, et al. HTLV-I positive spastic paraparesis in a temperate zone. Lancet. 1989;1:556–557.CrossRefGoogle Scholar
13. Greaves, MF, Verbi, W. Tilley, R, et al. Human T-cell leukemia virus (HTLV)m the United Kingdom. Int J Cancer. 1984;33:795–806 CrossRefGoogle Scholar
14. Manzari, V, Grandilon, A, Barillari, G. et al. HTLV-I is endemicin. southern Italy: detection of the first infectious cluster in a white population. Int J Cancer. 1985;36:557–559.CrossRefGoogle Scholar
15. Gout, O, Gessain, A, Bolgert, FT et al. Chronic myelopathies associated with human T-lymphotropic virus type-1. A clinical, serologic. and immunovirologic study of ten patients in France. Arch Neurol. 1989;46:255–260.CrossRefGoogle Scholar
16. Levine, PH, Jaffe, E, Manns, A. Murphy, EL. Clark, J, Blattner, WA. Human T-cell lymphotropic virus type-1 and adult T-cell leukemia lymphoma outside Japan and the Caribbean basin. Yale J Biol Med. 1988;61:215–222.Google ScholarPubMed
17. Gallo, R, Shsks, A, Wang-Stall, F. Origin of human T-cell leukemia lymphoma virus. Lancet. 1983;2:962–963.CrossRefGoogle Scholar
18. lshida, T, Hinuma, Y. Origin of Japanese HTLV-I. Nature. 1986;322:504.Google Scholar
19. lshida, T, Yamamoto, K. Omoto, K. A seroepidemiologic survey of HTLV-I in the Philippines Ini J Epidemiol. 1988;17:625–628.Google Scholar
20. Saxton, EH. Lee, H, Swanson, P, et al. Detection of human T-cell leukemia/lymphoma virus type-1 in a transfusion recipient with chronic myelopathy. Neurology. 1989;39:841–844.CrossRefGoogle Scholar
21. Cohen, N, Munoz, A. Reitz, BA, et al. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med. 1989;320:1172–1176.CrossRefGoogle ScholarPubMed
22. Barnes, D. HTLV-I: to test or not to test. Science. 1988;242:372–373.CrossRefGoogle ScholarPubMed
23. Gore, I. Decker, WD, Snyder, TL. Isolation andmolecular characterization of HTLV-I and HTLV-II from the peripheral blood of intravenous drug users. J Cell Biochem. 1989;13B:272.Google Scholar
24. Robert-Guroff, M, Weiss, SH. Giron, JA. Prevalence of antibodies to HTLV-I. II, and Ill in intravenous drug abusers from an AIDS endemic region. JAMA. 1986;255:3133–3137.CrossRefGoogle Scholar
25. Murphy, E. Figueroa, JP. Gibbs, W. et al. Sexual transmission of human T-lymphotropic virus type-1 (HTLV-I). Ann Intern Med. 1989;111:555–560.CrossRefGoogle Scholar
26. Williams, A, Fang, C, Slamon, D, et al. Seroprevalence and epidemiologic correlates of HTLV-I infection in U.S. blood donors. Science. 1988;40:643–646.CrossRefGoogle Scholar
27. Bartholomew, C, Saxinger, W. Clark, J, et al. Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA. 1987;257:2604–2608.CrossRefGoogle ScholarPubMed
28. Nakamura, T. Matsuo, H. Shirabe, S, et al. Familial clusters in human T-cell lymphotropic virus type-l-associated myelopathy. Arch Neurol 1989;46:250–251.CrossRefGoogle ScholarPubMed
29. Sugiyama, H, Doi, H, Yamaguchi, K. Tsuji, Y, Miyamoto, T, Hino, S. Significance of postnatal mother-to-child transmission of human virus type-1 on the development of adult T-cell leukemia/lymphoma. J Med Virol. 1986;20:253–260.CrossRefGoogle Scholar
30. Miller, G, Pegram, ST Kirkwood, B. et al. Ethnic composition, age and sex, together with location and standard of housing as determinants of HTLV-I infection in an urban Trinidadian community. Int J Cancer. 1986;38:801–808.CrossRefGoogle Scholar
31. Murphy, E, Cahsher, C. Gifueroa, J, Gibbs, WN. Blattner WA HTLV-I infection and arthropod vectors. N Engl J Meo. 1989;320:1146.Google ScholarPubMed
32. Lee, S. Mastushita, K, Machida, J. et al. Human T-cell leukemia virus type-1 infection in hemodialysis patients. Cancer. 1987;60:1474–1478.3.0.CO;2-Y>CrossRefGoogle Scholar
33. Sato, Y, Shroma, Y. Concurrent Infections with Strongyloides and T-cell leukemia virus and their possible effects on immune responses of host. Clin Immunol Immunopathol. 1989;52:214–224.CrossRefGoogle Scholar
34. Motoharus, S, Hattori, S. Hirayama, Y, et al. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemic cell DNA. Pro Natl Acad Sci U.S.A. 1983;80:3618–3622.Google Scholar
35. Seike, M. Eddy, R, Shows, TB, Yoshida, M. Nonspecific integration of the HTLV provirus genome into adult T-cell leukemia. Nature. 1984;309:640–642.CrossRefGoogle Scholar
36. Cann, AJ. Rosenblatt, J. Wachsman, W, Shah, NP, Chen, IS. Identiflca-of the gene responsible for human T-cell leukemia virus transcriptional regulation. Nature. 1985;318:571–574.CrossRefGoogle ScholarPubMed
37. Poteat, HT, Kadison, P, McGuire, K, et al. Response of human T-cell leukemia virus type I long terminal repeat to cyclic AMP. J Virol. 1989;63:1604–1611.CrossRefGoogle ScholarPubMed
38. Nagata, K, Ohtani, K, Nakamura, M, Sugamura, K. Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40 tax protein in the human T-cell line, Jurkat. J Virol. 1989;63:3220–3226.CrossRefGoogle Scholar
39. Kronke, M. Leonard, WJ, Depper, JM, Greene, WC. Deregulation of interleukin-2 receptor gene expression on HTLV-I induced adult T-cell leukemia. Science. 1985:228:1215–1217.CrossRefGoogle ScholarPubMed
40. Tokudome, S, Tokunuga, O, Shimamato, Y, et al. Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic type I virus carriers in Saga, Japan. Cancer Res. 1989:49:226–228.Google ScholarPubMed
41. Kondo, T. Kono, H. Miyamoto, N, et al. Age-and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer. 1989;43:1061–1064.CrossRefGoogle ScholarPubMed
42. Kinoshita, K. Amagasaki, T, Ikeda, S, et al. Preleukemic state of adult T-cell leukemia: abnormal T lymphocytosis induced by human adult T-cell leukemia-lymphoma virus. Blood. 1985;66:120–127.CrossRefGoogle Scholar
43. Yamaguchi, K. Nishimura, H. Kohrogi, H, et al. A proposal for smoldering adult T-cell leukemia: a clinicopathologic study of five cases. Blood. 1983;62:758–766.CrossRefGoogle ScholarPubMed
44. Kawano, F. Yamaguchi, K, Nishimura, H, Tsuda, H, Takatsuki, K. Variation in the clinical courses of adult T-cell leukemia. Cancer. 1985;55:851–856.3.0.CO;2-J>CrossRefGoogle ScholarPubMed
45. Vukelja, SJ. Weiss, RB, Perry, DJ. Longo, DL. Eosinophilia associated with adult T-cell leukemia/lymphoma. Cancer. 1988;62:1527–1530.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
46. Scully, R, Mark, E, McNeedy, W. et al. Case records of the Massachusetts General Hospital. N Engl J Med. 1989;321:663–675.Google Scholar
47. Blayney, DW, Jaffe, ES. Fisher, RI. et al. The human T-cell leukemia/lymphoma virus, lymphoma, lytic bone lesions, and hypercalcemia. Ann Intern Med. 1983;98:144–151.CrossRefGoogle ScholarPubMed
48. Yoshika, R, Yamaguchi, K. Yoshinaga, T. et al. Pulmonary complications in patients with adult T-cell leukemia. Cancer. 1985;55:249l–2494.Google Scholar
49. Fbkumoto, S, Matsumoto, T, Ikeda, K. et al. Clinical evaluation of calcium metabolism in adult T-cell leukemia/lymphoma. Arch Intern Med. 1988;148:921–925.CrossRefGoogle Scholar
50. Kwok, S, Ehrlich, G, Poiesz, B, Kalish, R. Snisky, JJ. Enzymatic amplification of HTLV-I proviral sequences from peripheral blood mononuclear cells and infected tissues. Blood. 1989;72:1117–1123.CrossRefGoogle Scholar
51. Shimoyama, M, Ota, K. Kikuchi, M, et al. Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. J Clin Oncol. 1988:6:1088–1097.CrossRefGoogle ScholarPubMed
52. Tamura, K, Makino, S. Araki, Y, Imamura, T, Seita, M. Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia. Cancer. 1987;59:1059–1062.3.0.CO;2-M>CrossRefGoogle ScholarPubMed
53. Waldmann, TA, Goldman, CK. Bongiovanni, KF, et al. Therapy of patients with human T-cell lymphotropic virus-I-induced adult T-cell leukemia with antitat, a monoclonal antibody to the receptor for interleukin-2. Blood. 1988;72:1805–1816.CrossRefGoogle Scholar
54. Gessain, A. Barin, F, Vernant, JC, et al. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet. 1985;2:407–409.CrossRefGoogle Scholar
55. Osarne, M, Usuku, K, Izumo, S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986:1:1031–1032.Google Scholar
56. Roman, G, Osarne, M. Identity of HTLV-I associated tropical spastic paraparesis and HTLV-I associated myelopathy. Lancet. 1988;1:651.CrossRefGoogle ScholarPubMed
57. Shibasaki, H. Endo, C, Kuroda, Y, et al. Clinical picture of HTLV-I associated myelopathy. J Neurol Sci. 1988;87:15–24.CrossRefGoogle ScholarPubMed
58. Grimaldi, LM, Roos, RP, Devare, SG. et al. HTLV-L associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody. Arm Neurol. 1988;24:727–731.Google Scholar
59. Kira, J. Minato, S. Itoyama, Y, Goto, I, Kato, M, Hasuo, K. Leukoenceph-alopathy in HTLV-l-associated myelopathy: MRI and EEG data. J Neurol Sci. 1988;87:221–232.CrossRefGoogle ScholarPubMed
60. Yonenaga, Y, Arimura, K. Suehara, M, Arimura, YT Osarne, M. Electro-encephalographic abnormalities in human T-cell lymphotropic virus type I-associated myelopathy. Arch Neurol. 1989;46:513–516.CrossRefGoogle Scholar
61. Kakigi, R, Shibasaki, H, Kuroda, YT et al. Multimodality evoked potentials in HTLV-I associated myelopathy. J Neurol, Neuronu rg Psychiatry. 1988:51:1094–1096.CrossRefGoogle ScholarPubMed
62. Ijichi, S, Eiraku, N, Osarne, M, et al. In vitro modulation of lymphocyte proliferation by predunisolone and interferon-alpha in patients with HTLV-I associated myelopathy (HAM). J Neurol. 1989;23:175–178.Google Scholar
63. Matsuo, H, Nakamura, T. Shibayama, K, Nagasato, K, Tsujihata, M, Nagataki, S. Long-term followup of immunomodulation in treatment of HTLV-I-associated myelopathy. Lancet. 1989;1:790.CrossRefGoogle Scholar
64. Iwasaki, Y, Kinoshita, M, Ikeda, K. Takamiya, K. Human T-lymphotropic virus type I-associated myelopathy presenting as spinocerebellar syndrome. Ann Neurol. 1989:25:419–420.CrossRefGoogle ScholarPubMed
65. Kano, M. Mitsuhata, Y, Kishida, S, et al. Shy-Drager Syndrome and human T-cell lymphotropic virus type-1 infection. Ann Neurol. 1989;25:420–421.CrossRefGoogle Scholar
66. Araga, S, Takahashi, K, Ooi S: Subacute meningoencephalitis associated with human T-lymphotropic virus type-1 (HTLV-I) Report of a case. Acta Neurol 1989:79:361–365.CrossRefGoogle Scholar
67. Reddy, EP, Sandburg-Wollheim, M, Mettus, Ry. Ray, PE. DeFreitas, E, Koprowski, H. Amplification and molecular cloning of HTLV-I sequences from DNA of multiple sclerosis patients. Science. 1989;243:529–533.CrossRefGoogle ScholarPubMed
68. Gebarski, SS, Gabrielsen, TO, Gilman, S, Knake, JE. Latack, JT, Aisen, AM. The initial diagnosis of multiple sclerosis: clinical impact of magnetic resonance imaging. Ann Neurol. 1985:17:469–474.CrossRefGoogle ScholarPubMed